@fredhutch.org
Making life beyond cancer a reality. fredhutch.org
@fredhutch.orgScientists at Fred Hutch Cancer Center found that the molecular regulator RNA—specifically tRNA, a type of RNA—may be able to influence the nature of prostate cancer cells and how they respond to treatment. Via @newsweek.com https://bit.ly/3UjeKz9
@fredhutch.orgNew treatments are transforming breast cancer care. A new @nejm.org review by Fred Hutch's Sara Hurvitz, MD, highlights advances in targeted therapies, antibody-drug conjugates and immunotherapy, bringing more personalized treatment options to patients across disease subtypes. https://bit.ly/4icTcgJ
@harmitmalik.bsky.socialReposted by @fredhutch.orgwww.fredhutch.org/content/www/...
Wonderful writeup by Kelsey Woodruff on thesis from Caroline Langley, and the final corresponding author research paper from my colleague @memerman.bsky.social's amazing career
@harmitmalik.bsky.socialReposted by @fredhutch.orgOne stop codon to evade two divergent immune systems
www.fredhutch.org/content/www/...
Great writeup by Ashley Person @fredhutch.org
Original paper by @tamanash.bsky.social here: www.science.org/doi/10.1126/...
@fredhutch.orgThank you to all the creators and their communities who helped us make Raids for Research a big success! 🥳🎉
@fredhutch.orgA @nature.com study led by Yeon Soo Kim in the Hsieh Lab at Fred Hutch reveals that a single transfer RNA (tRNA) helps determine whether prostate cancer remains treatment-sensitive or becomes resistant, opening new avenues in precision oncology. https://bit.ly/4zG67xV
@fredhutch.orgHow clinical trials are changing treatment duration, how translational science is helping overcome immunotherapy resistance and why bringing research closer to patients matters: Listen to the latest Oncology Insights with @pgrivasmdphd.bsky.social and Ajay Gopal. https://bit.ly/4ekydGr
@fredhutch.orgCongratulations to Alex Doan, who was recently named the 2026 recipient of the Dorothy L. Simpson Leadership Award from the Seattle chapter of the ARCS Foundation. Read more: https://bit.ly/4yvwVk9
@fredhutch.orgFred Hutch and UW are recruiting a physician-scientist faculty member in Radiation Oncology. Help advance translational cancer research while delivering exceptional patient care and training the next generation of clinicians. Apply: https://apply.interfolio.com/192383
@fredhutch.orgCongratulations to Drs. Sujatha Srinivasan and Alex Reiner, who received R01 NIH awards to support development of biomarkers for disease diagnosis and risk detection. Read more about their research: https://bit.ly/4hYJIpf
@uwmedicine.bsky.socialReposted by @fredhutch.orgGetting screened for breast cancer is an important way to catch it early when it’s easier to treat. UW Medicine and @fredhutch.org recommend that women at average risk have a screening mammogram every one to two years beginning at age 40.
Read the full article to learn more.
@fredhutch.orgFred Hutch is recruiting an open-rank faculty member in cancer immunotherapy. Join a leading immunotherapy research community and help advance next-generation treatments from discovery to clinical translation. Apply: https://apply.interfolio.com/188969
@fredhutch.orgFrom bone marrow transplantation to T-cell immunotherapy, the legacy of Dr. E. Donnall Thomas continues to shape cancer care. This week, researchers from around the world gathered in Seattle for the inaugural Dr. E. Donnall Thomas Symposium. 📸
@fredhutch.orgFred Hutch is recruiting an Assistant Professor in Cancer Prevention. We're seeking researchers focused on metabolism, nutrition, physical activity, toxicology and the biological mechanisms of carcinogenesis to advance cancer prevention science. Apply: https://apply.interfolio.com/191911
@fredhutch.org$3.5M NIH grant supports a Fred Hutch-led clinical trial to find the optimal dose of PTCy, a drug used to help prevent #GVHD after bone marrow #transplant. Researchers will test whether lower doses can reduce side effects while maintaining benefits. https://bit.ly/4hd8MZu
@fredhutch.orgNew research from Fred Hutch and UW could help more patients with triple-negative breast and tubo-ovarian cancers benefit from targeted therapies. HRDefine more precisely identifies tumors likely to respond to PARP inhibitors, advancing precision medicine. https://bit.ly/4iJ8v1E
@fredhutch.orgWhen Margie Wilson was diagnosed with #endometrialcancer in 2016 after she experienced unexplained bleeding, she knew nothing about cancer. A decade later, Wilson is a vocal patient advocate who speaks candidly about her diagnosis and treatment. https://bit.ly/4dt6RgX
@fredhutch.orgIncredible! Thanks so much for your support! 💙
@roseofbattle.comReposted by @fredhutch.orgReminder that this week I'm still raising funds for @fredhutch.org! They do lots of cancer research and treatment, and I strongly believe in what they do.
And for YOUUUU, you can enter our art raffle for a shikishi board commission by @itshappymerci.bsky.social! Open until 11:59 pm EDT 9/24!
@fredhutch.orgPretty neat indeed! 🤩 Grateful for your support! 💙
